◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
Amid Xbox "Reset," Microsoft Is Having Its Worst Month In 26 Years
5sources
7articles
4velocity
+0%since first seen
21d agofirst detected
🌍 Cross-language spread
Archynetys detected this story across 2 language editions of the world's news.
🇬🇧
English
Jul 1, 00:00 UTC
🇫🇷
French
Jul 2, 17:30 UTC · Le Figaro
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (7)
- Microsoft (MSFT) Stock Falls Amid Market Uptick: What Investors Need to Know Yahoo Finance UK · 22d ago
- Microsoft Stock Is Near Its 52-Week Low: 2 Reasons to Buy MSFT Here Before It Rebounds Barchart.com · 22d ago
- Microsoft Corporation (MSFT) Is A Top Richard Chilton AI Stock Yahoo Finance · 22d ago
- Despite Dropping 26% This Year, Microsoft is a No-Brainer Buy Yahoo Finance · 22d ago
- Dear Microsoft Stock Fans, Mark Your Calendars for August 1 Barchart.com · 22d ago
- Microsoft: When Uncertainty Rules, Even Attractive Valuations Don't Matter (NASDAQ:MSFT) Seeking Alpha · 22d ago
- Amid Xbox "Reset," Microsoft Is Having Its Worst Month In 26 Years GameSpot · 22d ago
Related trends
▲ Peaking
Business
Is the All-New Range Rover GT Stepping on Jaguar’s Tail?
▲ Peaking
Business
ChatGPT Led to a Man’s Near-Fatal Health Crisis, Lawsuit Claims
OpenAI faces lawsuits alleging that ChatGPT encouraged an Alabama woman's suicide and contributed to a man's near-fatal health crisis.
▲ Peaking
Business
Google Expands in Miami After Its Billionaire Founders Buy Homes
Google is significantly expanding its Miami footprint following the relocation of its billionaire co-founders to South Florida.
▲ Peaking
Business
Nike Reboots Its Troubled China Operations
▲ Peaking
Business
US Senate panel approves bill to crack down on Chinese vehicles
▲ Peaking
Business
Why Arrowhead Shot Sky-High, While Ionis Toppled
Arrowhead Pharmaceuticals shares surged following positive Phase 3 trial results for its lipid-lowering drug, impacting competitor Ionis.